How serious is FDA warning about revolutionary blood-cancer treatment?— Harvard Gazette

Dana-Farber Cancer Institute researcher details promise, peril of CAR T-cell therapy, which enlists body’s immune system to fight disease.

Susan B. Nichols on LinkedIn: Bluebird submits sickle cell gene therapy to FDA, setting up race with…

Susan B. Nichols sur LinkedIn : ARM Releases Statement on MVP Act Re-Introduction - Alliance for…

Tracie-Jo (TJ) Crowthers on LinkedIn: #thankyou #project #recruiter #scienceandtechnology #biotechnology…

Susan B. Nichols on LinkedIn: AstraZeneca says its $200M cash bet on Ionis' ATTR drug is paying off —…

Mark Flower on LinkedIn: Julie Kanter, MD, on Preparing for Anticipated Approval of Lovo-Cel for…

Mark Flower on LinkedIn: #celltherapy #cryopreservation #apheresis #donoridentification…

James Wang, PhD on LinkedIn: Phase 1 trial to open into SC291, cell therapy for AAV

Natasha Hansjee en LinkedIn: Excited to be part of this panel, to learn and to engage!

Susan B. Nichols en LinkedIn: FDA to back accelerated approval pathway for gene therapies (NASDAQ:SRPT)

James Wang, PhD on LinkedIn: Inability of Macrophages To Penetrate Tumors Could Explain Cell Therapy…

Eric Smith (@ESmithMDPhD) / X

Natasha Hansjee på LinkedIn: Precision oncology enabled by digital solutions

James Wang, PhD on LinkedIn: CAR-T May Be a Silver Bullet Against Cancer—and Here's What Else It Can Do

Eric Smith (@ESmithMDPhD) / X

Natasha Hansjee en LinkedIn: Excited to be part of this panel, to learn and to engage!